Indo Us Bio-Tech 過去の業績
過去 基準チェック /26
Indo Us Bio-Tech has been growing earnings at an average annual rate of 28%, while the Food industry saw earnings growing at 14.1% annually. Revenues have been growing at an average rate of 16.9% per year. Indo Us Bio-Tech's return on equity is 14.4%, and it has net margins of 11.5%.
主要情報
28.0%
収益成長率
19.6%
EPS成長率
| Food 業界の成長 | 17.6% |
| 収益成長率 | 16.9% |
| 株主資本利益率 | 14.4% |
| ネット・マージン | 11.5% |
| 前回の決算情報 | 30 Jun 2024 |
最近の業績更新
Recent updates
収支内訳
Indo Us Bio-Tech の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。
収益と収入の歴史
| 日付 | 収益 | 収益 | G+A経費 | 研究開発費 |
|---|---|---|---|---|
| 30 Jun 24 | 784 | 90 | 39 | 0 |
| 31 Mar 24 | 728 | 83 | 40 | 0 |
| 31 Dec 23 | 752 | 105 | 32 | 0 |
| 30 Sep 23 | 686 | 82 | 33 | 0 |
| 30 Jun 23 | 668 | 81 | 32 | 0 |
| 31 Mar 23 | 617 | 72 | 31 | 0 |
| 31 Dec 22 | 559 | 58 | 21 | 0 |
| 30 Sep 22 | 527 | 57 | 29 | 0 |
| 30 Jun 22 | 514 | 54 | 27 | 0 |
| 31 Mar 22 | 501 | 51 | 26 | 0 |
| 31 Dec 21 | 494 | 55 | 21 | 0 |
| 30 Sep 21 | 488 | 59 | 16 | 0 |
| 30 Jun 21 | 444 | 54 | 16 | 0 |
| 31 Mar 21 | 401 | 49 | 16 | 0 |
| 31 Dec 20 | 394 | 39 | 17 | 0 |
| 30 Sep 20 | 386 | 28 | 17 | 0 |
| 30 Jun 20 | 392 | 27 | 17 | 0 |
| 31 Mar 20 | 398 | 25 | 18 | 0 |
| 31 Dec 19 | 376 | 24 | 7 | 0 |
| 30 Sep 19 | 354 | 22 | 8 | 0 |
| 30 Jun 19 | 354 | 22 | 9 | 0 |
| 31 Mar 19 | 353 | 21 | 8 | 0 |
| 31 Mar 18 | 294 | 14 | 6 | 0 |
| 31 Mar 17 | 245 | 4 | 7 | 0 |
| 31 Mar 16 | 190 | 4 | 5 | 0 |
| 31 Mar 15 | 196 | 5 | 5 | 0 |
| 31 Mar 14 | 148 | 3 | 4 | 0 |
質の高い収益: 541304 has high quality earnings.
利益率の向上: 541304's current net profit margins (11.5%) are lower than last year (12.1%).
フリー・キャッシュフローと収益の比較
過去の収益成長分析
収益動向: 541304's earnings have grown significantly by 28% per year over the past 5 years.
成長の加速: 541304's earnings growth over the past year (12.2%) is below its 5-year average (28% per year).
収益対業界: 541304 earnings growth over the past year (12.2%) did not outperform the Food industry 16.4%.
株主資本利益率
高いROE: 541304's Return on Equity (14.4%) is considered low.